Minerva Neurosciences Inc (NERV): Next-Year EPS Estimate 80.51%
As of 2026-06-04, Minerva Neurosciences Inc (NERV) has a next-year EPS growth estimate of 80.51%.
On 2026-05-11, analyst consensus for NERV's next-year EPS growth shifted from 73.06% to 80.51% — a positive change of 7.45 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at -87.04%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 80.51%
- EPS growth this year
- -87.04%
- EPS next quarter (est)
- -$0.19
- Last price
- $4.78
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 80.51% | -87.04% | -$0.19 | $4.78 |
| 2026-06-03 | 80.51% | -87.04% | -$0.19 | $4.68 |
| 2026-06-02 | 80.51% | -87.04% | -$0.19 | $4.75 |
| 2026-06-01 | 80.51% | -87.04% | -$0.19 | $4.84 |
| 2026-05-31 | 80.51% | -87.04% | -$0.19 | $4.91 |
| 2026-05-28 | 80.51% | -87.04% | -$0.19 | $5.00 |
| 2026-05-27 | 80.51% | -87.04% | -$0.19 | $5.26 |
| 2026-05-26 | 80.51% | -87.04% | -$0.19 | $5.22 |
| 2026-05-25 | 80.51% | -87.04% | -$0.19 | $5.26 |
| 2026-05-24 | 80.51% | -87.04% | -$0.19 | $5.26 |
| 2026-05-21 | 80.51% | -87.04% | -$0.19 | $5.30 |
| 2026-05-20 | 80.51% | -87.04% | -$0.19 | $5.03 |
| 2026-05-19 | 80.51% | -87.04% | -$0.19 | $4.36 |
| 2026-05-18 | 80.51% | -87.04% | -$0.19 | $4.74 |
| 2026-05-17 | 80.51% | -87.04% | -$0.19 | $5.21 |
| 2026-05-14 | 80.51% | -87.04% | -$0.19 | $5.50 |
| 2026-05-13 | 80.51% | -87.04% | -$0.19 | $5.74 |
| 2026-05-12 | 80.51% | -87.04% | -$0.19 | $5.60 |
| 2026-05-11 | 80.51% | -87.04% | -$0.19 | $5.63 |
| 2026-05-10 | 73.06% | -35.27% | -$0.19 | $5.88 |
| 2026-05-07 | 73.06% | -35.27% | -$0.19 | $6.12 |
| 2026-05-06 | 73.06% | -35.27% | -$0.19 | $6.23 |
| 2026-05-05 | 62.16% | 15.34% | -$0.17 | $6.25 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Minerva Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Minerva Neurosciences Inc (NERV) has a next-year EPS growth estimate of 80.51%, based on analyst consensus.
When was the latest EPS estimate revision for NERV?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 73.06% to 80.51%.
What sector and industry does Minerva Neurosciences Inc belong to?▾
Minerva Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NERV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Minerva Neurosciences Inc (NERV) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports